FabrikaCr The Securities and Trade Commission plans to vote next week on a proposal to completely roll back a 20-year-old rule that bans exchanges, alternative trading systems, and wholesalers from executing trades that ignore or “trade through” the national best bid or offer. The rule has helped ensure fair treatment for individual investors. SEC Chairman Paul Atkins, though, has opposed the rule...
FabrikaCr The Securities and Trade Commission plans to vote next week on a proposal to completely roll back a 20-year-old rule that bans exchanges, alternative trading systems, and wholesalers from executing trades that ignore or “trade through” the national best bid or offer. The rule has helped ensure fair treatment for individual investors. SEC Chairman Paul Atkins, though, has opposed the rule, fearing unintended consequences on the long-term growth of financial markets. Other arguments against the trade-through ban include increased transaction costs, its impact on the speed of execution, and fragmentation of trading, Bloomberg reported. In comments made on Thursday at a fintech conference, Jamie Selway, SEC Trading and Markets Division director, said the vote on repealing the rule is "genuinely on the table." In expanding on Atkins' view of the matter, Selway said, "If you follow his perspectives, you have a pretty good indicator of our direction of travel." The SEC meeting is scheduled for 10:00 AM ET on June 11. More on Nasdaq, Intercontinental Exchange, etc. Nasdaq, Inc. (NDAQ) Presents at Piper Sandler Global Exchange and Fintech Conference Transcript Intercontinental Exchange, Inc. (ICE) Presents at Piper Sandler Global Exchange and Fintech Conference Transcript Nasdaq, Inc. (NDAQ) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript Nasdaq U.S. equity trading volume rose 6.6% in May and 17% Y/Y Anthropic picks Morgan Stanley, Goldman Sachs to lead IPO - report
AstraZeneca CFO Aradhana Sarin discusses how the pharmaceutical company is broadening its US shareholder base and plans to generate $80 Billion in revenue by 2030. She speaks with Bloomberg's Katie Greifeld. (Source: Bloomberg)
AstraZeneca CFO Aradhana Sarin discusses how the pharmaceutical company is broadening its US shareholder base and plans to generate $80 Billion in revenue by 2030. She speaks with Bloomberg's Katie Greifeld. (Source: Bloomberg)
Ten years after the vote, our economy is battered – and our national conversation darkens by the day. Still, there is reason for hope When the anniversary comes, later this month, few will be in the mood to look back. All the political talk will be of the Makerfield byelection, of the future of this government and this prime minister. And yet, it would be wise to reflect on what happened on 23 Jun...
Ten years after the vote, our economy is battered – and our national conversation darkens by the day. Still, there is reason for hope When the anniversary comes, later this month, few will be in the mood to look back. All the political talk will be of the Makerfield byelection, of the future of this government and this prime minister. And yet, it would be wise to reflect on what happened on 23 June 2016 – if only because the choices Keir Starmer and his would-be successors face, indeed the entire political and cultural landscape we now inhabit, are informed or were shaped by that event. We are living in Brexit Britain. A useful prompt comes from the upcoming two-part BBC series Brexit: A Very British Civil War , made by the master documentarian Norma Percy. Speaking to (nearly) every key player, it brings it all back – the red bus , “take back control”, the pantomime river battle of Nigel Farage v Bob Geldof . Jonathan Freedland is a Guardian columnist Do you have an opinion on the issues raised in this article? If you would like to submit a response of up to 300 words by email to be considered for publication in our letters section, please click here . Continue reading...
JHVEPhoto/iStock Editorial via Getty Images In the past two months, Chevron Corporation ( CVX ) has remained flat with approximately -0.7% returns from my previous coverage . This can tell us that it did not benefit that much from the skyrocketing oil prices despite its upstream-heavy operations. Even so, I understand the cautious market stance as oil price swings remain sharp. Global oil market d...
JHVEPhoto/iStock Editorial via Getty Images In the past two months, Chevron Corporation ( CVX ) has remained flat with approximately -0.7% returns from my previous coverage . This can tell us that it did not benefit that much from the skyrocketing oil prices despite its upstream-heavy operations. Even so, I understand the cautious market stance as oil price swings remain sharp. Global oil market dynamics continue to influence short-term investor sentiments, which I will discuss more later. Nonetheless, a strong buy reiteration fits Chevron as it opens new buying opportunities, supported by fundamentals and valuation. Technicals adhere to these as Chevron starts to regain its momentum. Q1 2026: Resilience Amid Market Turbulence In the first three months of 2026, the global oil market has experienced a lot of disruptions, beginning with the civil unrest in Iran in January. Tensions escalated in mid-February as the US and Israel began to intervene. But the war broke out after Iran retaliated and attacked neighboring countries like Saudi Arabia, Kuwait, Oman, Bahrain, and the UAE. These events immediately sent oil prices to the $100-per-barrel benchmark and caused fear premiums in the oil market. For many, this became worrisome as oil and fuel supply and price concerns spread. But for many upstream-heavy companies, this became an opportunity to enjoy stronger pricing. The same applies to Chevron Corporation, as you saw in its most recent performance. In Q1 2026, its operating revenue amounted to $48.6 billion , up by 2.1% YoY from $47.6 billion. This served as its comeback from its weaker performance in all quarters of 2025 due to the negative change in revenues on a YoY basis. Just by looking at its revenue trend, my view about Chevron benefiting from the Iran War was proven right. This should not be surprising because higher oil prices incentivize oil producers. In short, this meant a higher realized sales price for Chevron. If you look at sales alone, the amount incr...
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data infrastructure industry, including Oracle (NYSE:ORCL) and its peers.
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data infrastructure industry, including Oracle (NYSE:ORCL) and its peers.
The Federal Reserve logo is visible on the William McChesney Martin Jr. Building on December 9, 2025 in Washington, DC. Andrew Harnik | Getty Images News | Getty Images Chances that the Federal Reserve increases interest rates this year shot up from 25.3% to 52% in the last week on prediction markets platform Kalshi. Those odds come after Friday's report from the Bureau of Labor Statistics reveale...
The Federal Reserve logo is visible on the William McChesney Martin Jr. Building on December 9, 2025 in Washington, DC. Andrew Harnik | Getty Images News | Getty Images Chances that the Federal Reserve increases interest rates this year shot up from 25.3% to 52% in the last week on prediction markets platform Kalshi. Those odds come after Friday's report from the Bureau of Labor Statistics revealed nonfarm payrolls hit 172,000, comfortably exceeding Dow Jones expectations of 80,000. A Fed hike before July 2027 also jumped from 54% to 65% in the past week on Kalshi. Fed rates increasing mean the Federal Reserve raises interest rates to stop the economy from overheating. With a higher-than-expected job report and the annual core inflation rate hitting 3.3% in April, economists see a fed hike approaching. "I think there actually could be one this year, and for good reason. Inflation is pretty sticky," said former Federal Reserve Vice Chairman Roger Ferguson to CNBC's " Squawk Box ." The CME's Fedwatch tool recorded a 50% chance of a higher rate this year. For other economists, the move is for the Fed to not do anything, for now. "Payroll Blowout! We've gained more and more confidence in the last prints that the Fed doesn't have to be worried about the labor market," Lindsay Rosner, Goldman Sachs Asset Management head of multi-sector fixed-income investing, wrote in a note. "Laser focused on inflation and it will all come down to the duration of this War to determine the Fed's next move. For now, the move is to not move: HOLD." Sectors like leisure and hospitality recorded 70,000 jobs, the highest out of any sector. Meanwhile local government added 55,000 jobs, social assistance added 12,000 and health care brought in 35,000, roughly in line with its average. Disclosure: CNBC and Kalshi have a commercial relationship that includes customer acquisition and a minority investment. Choose CNBC as your preferred source on Google and never miss a moment from the most trusted ...
Cybercriminals, part of a gang known as Silent Ransom Group, have sent people pretending to be IT support employees to law firms' offices, where the criminals have stolen data using USB drives or remote access tools.
Cybercriminals, part of a gang known as Silent Ransom Group, have sent people pretending to be IT support employees to law firms' offices, where the criminals have stolen data using USB drives or remote access tools.
The State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) provides low-cost, passive exposure to established healthcare giants, while the Simplify Health Care ETF (NYSEMKT:PINK) offers an active strategy targeting medical breakthroughs. Investors evaluating the healthcare sector could choose between the stability of established medical giants and the high-growth potential of cutting-edge i...
The State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) provides low-cost, passive exposure to established healthcare giants, while the Simplify Health Care ETF (NYSEMKT:PINK) offers an active strategy targeting medical breakthroughs. Investors evaluating the healthcare sector could choose between the stability of established medical giants and the high-growth potential of cutting-edge innovation. While both funds operate within the medical sector, they differ significantly in their investment philosophies. The State Street fund tracks a well-known index, whereas the Simplify fund employs active management led by Michael Taylor, who utilizes over 20 years of experience to navigate the complexities of the biotech and medtech industries. Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield. Continue reading